InvestorsHub Logo
Followers 827
Posts 119559
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 405

Tuesday, 02/19/2019 4:40:04 PM

Tuesday, February 19, 2019 4:40:04 PM

Post# of 866
Keytruda monotherapy in 2L-HCC misses primary endpoints in KEYNOTE-240 study with HR-0.78 for both PFS and OS:

https://www.businesswire.com/news/home/20190219005993/en/Merck-Update-KEYNOTE-240-Phase-3-Study-KEYTRUDA

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News